Third Harmonic Bio (THRD) Earnings Date & Reports

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

THRD is expected to report earnings to rise 7.58% to -35 cents per share on March 26

Third Harmonic Bio THRD Stock Earnings Reports

Q4'24

Est.

$-0.35

Q3'24

Missed

by $0.03

Q2'24

Missed

by $0.01

Q1'24

Beat

by $0.11

Q4'23

Beat

by $0.14

The last earnings report on November 07 showed earnings per share of -33 cents, missing the estimate of -29 cents. With 250.09K shares outstanding, the current market capitalization sits at 155.45M.

View a ticker or compare two or three

Compare

THRD